{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:46:39Z","timestamp":1791279999381,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.tiv.2017.03.007","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T17:17:50Z","timestamp":1489857470000},"page":"189-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Cytotoxicity and genotoxicity of lipid nanocapsules"],"prefix":"10.1016","volume":"41","author":[{"given":"Ga\u00ebl","family":"Le Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Moche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Nesslany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Lagarce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2017.03.007_bb1000","series-title":"Recommandations for toxicological evaluation of nanoparticle medicinal products (version 2)","author":"AFSSAPS (Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9)","year":"2011"},{"issue":"8","key":"10.1016\/j.tiv.2017.03.007_bb0005","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1002\/jps.22111","article-title":"The effect of novel surfactants and Solutol HS 15 on paclitaxel aqueous solubility and permeability across a Caco-2 monolayer","volume":"99","author":"Alani","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.tiv.2017.03.007_bb0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/bp00024a017","article-title":"Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations","volume":"9","author":"Altman","year":"1993","journal-title":"Biotechnol. Prog."},{"issue":"1","key":"10.1016\/j.tiv.2017.03.007_bb0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.envres.2003.11.004","article-title":"In vitro effects on macrophages induced by noncytotoxic doses of silica particles possibly relevant to ambient exposure","volume":"96","author":"Balduzzi","year":"2004","journal-title":"Environ. Res."},{"issue":"5","key":"10.1016\/j.tiv.2017.03.007_bb0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1165\/ajrcmb.13.5.7576690","article-title":"Activation of murine macrophages by silica particles in vitro is a process independent of silica-induced cell death","volume":"13","author":"Claudio","year":"1995","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.tiv.2017.03.007_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","author":"Diehl","year":"2001","journal-title":"J. Appl. Toxicol."},{"issue":"6","key":"10.1016\/j.tiv.2017.03.007_bb0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.2042-7158.1997.tb06854.x","article-title":"The effect of monomers and of micellar and vesicular forms of non-ionic surfactants (Solulan C24 and Solulan 16) on Caco-2 cell monolayers","volume":"49","author":"Dimitrijevic","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.tiv.2017.03.007_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2014.02.005","article-title":"Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data","volume":"87","author":"Doktorovova","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.tiv.2017.03.007_bb0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/abbi.1995.1298","article-title":"Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity","volume":"319","author":"Dudeja","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tiv.2017.03.007_bb0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpharm.2010.06.006","article-title":"Cytotoxicity assessment of heparin nanoparticles in NR8383 macrophages","volume":"396","author":"Eidi","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.tiv.2017.03.007_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1383-5718(02)00249-8","article-title":"HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures","volume":"534","author":"Fenech","year":"2003","journal-title":"Mutat. Res."},{"issue":"4","key":"10.1016\/j.tiv.2017.03.007_bb0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2217\/nnm.14.124","article-title":"In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor","volume":"10","author":"Groo","year":"2015","journal-title":"Nanomedicine (London)"},{"issue":"6","key":"10.1016\/j.tiv.2017.03.007_bb0060","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1023\/A:1016121319668","article-title":"A novel phase inversion-based process for the preparation of lipid nanocarriers","volume":"19","author":"Heurtault","year":"2002","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.tiv.2017.03.007_bb0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2131\/jts.34.265","article-title":"Toxicity studies of Asahi Kasei PI, purified phosphatidylinositol from soy lecithin","volume":"34","author":"Honda","year":"2009","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.tiv.2017.03.007_bb0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1556-276X-7-77","article-title":"Dilemmas in the reliable estimation of the in-vitro cell viability in magnetic nanoparticle engineering: which tests and what protocols?","volume":"7","author":"Hoskins","year":"2012","journal-title":"Nanoscale Res. Lett."},{"issue":"3","key":"10.1016\/j.tiv.2017.03.007_bb0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11095-009-0024-y","article-title":"Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice","volume":"27","author":"Hureaux","year":"2010","journal-title":"Pharm. Res."},{"issue":"14","key":"10.1016\/j.tiv.2017.03.007_bb0080","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1096\/fj.01-0432com","article-title":"Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways","volume":"15","author":"Hwang","year":"2001","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.tiv.2017.03.007_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019850","article-title":"In vitro surfactant structure-toxicity relationships: implications for surfactant use in sexually transmitted infection prophylaxis and contraception","volume":"6","author":"Inacio","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tiv.2017.03.007_bb0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2014.03.022","article-title":"Quantitative assessment of nanoparticle surface hydrophobicity and its influence on pulmonary biocompatibility","volume":"183","author":"Jones","year":"2014","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.tiv.2017.03.007_bb0095","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4155\/tde.11.62","article-title":"Case studies with new excipients: development, implementation and regulatory approval","volume":"2","author":"Koo","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.tiv.2017.03.007_bb0100","first-page":"108","article-title":"Solutol HS15 as a novel excipient","volume":"2","author":"Ku","year":"2010","journal-title":"Pharm. Technol."},{"issue":"20","key":"10.1016\/j.tiv.2017.03.007_bb0105","doi-asserted-by":"crossref","first-page":"16683","DOI":"10.1074\/jbc.M011695200","article-title":"Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4","volume":"276","author":"Lee","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2017.03.007_bb0110","doi-asserted-by":"crossref","first-page":"942916","DOI":"10.1155\/2013\/942916","article-title":"Mechanisms of nanoparticle-induced oxidative stress and toxicity","volume":"2013","author":"Manke","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"1\u20132","key":"10.1016\/j.tiv.2017.03.007_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2011.03.056","article-title":"Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells","volume":"411","author":"Maupas","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.tiv.2017.03.007_bb2000","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1194\/jlr.M040212","article-title":"Analysis of inflammatory and lipid metabolic networks across RAW264.7 and thioglycolate-elicited macrophages","volume":"54","author":"Maurya","year":"2013","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.tiv.2017.03.007_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/toxsci\/kft222","article-title":"Tungsten carbide - cobalt (WC-Co) as a nanoparticulate reference positive control in in vitro genotoxicity assays","volume":"137","author":"Moche","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2017.03.007_bb0125","first-page":"1","article-title":"NTP comparative toxicology studies of corn oil, safflower oil, and tricaprylin (CAS Nos. 8001-30-7, 8001-23-8, and 538-23-8) in male F344\/N rats as vehicles for gavage","volume":"426","author":"National Toxicology Program (NTP)","year":"1994","journal-title":"Natl. Toxicol. Program Tech. Rep. Ser."},{"key":"10.1016\/j.tiv.2017.03.007_bb0130","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1289\/ehp.7339","article-title":"Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles","volume":"113","author":"Oberdorster","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tiv.2017.03.007_bb0135","series-title":"OECD Guideline for the Testing of Chemicals 487 - In Vitro Mammalian Cell Micronucleus Test","author":"OECD","year":"2010"},{"key":"10.1016\/j.tiv.2017.03.007_bb0140","first-page":"1335","article-title":"Effect of nanoparticles binding beta-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages","volume":"8","author":"Orlando","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.tiv.2017.03.007_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.tiv.2017.03.007_bb0150","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s11095-006-0022-2","article-title":"Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules","volume":"23","author":"Peltier","year":"2006","journal-title":"Pharm. Res."},{"issue":"1\u20132","key":"10.1016\/j.tiv.2017.03.007_bb0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijpharm.2011.07.028","article-title":"OPA quantification of amino groups at the surface of lipidic nanocapsules (LNCs) for ligand coupling improvement","volume":"419","author":"Perrier","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.tiv.2017.03.007_bb0160","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2009.08.010","article-title":"Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis","volume":"140","author":"Roger","year":"2009","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.tiv.2017.03.007_bb0165","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejps.2010.04.015","article-title":"Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells","volume":"40","author":"Roger","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.tiv.2017.03.007_bb0170","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejps.2013.06.013","article-title":"Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide","volume":"50","author":"Saliou","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.tiv.2017.03.007_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-5173(01)00660-3","article-title":"Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages","volume":"221","author":"Scholer","year":"2001","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.tiv.2017.03.007_bb0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(01)00882-1","article-title":"Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages","volume":"231","author":"Scholer","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.tiv.2017.03.007_bb0185","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1073\/pnas.0804897106","article-title":"Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome","volume":"106","author":"Sharp","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.tiv.2017.03.007_bb0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0024-3205(01)01392-3","article-title":"Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptors","volume":"70","author":"Shibuya-Fujiwara","year":"2001","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.tiv.2017.03.007_bb0195","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s11095-014-1481-5","article-title":"Mechanism of mucosal permeability enhancement of CriticalSorb(R) (Solutol(R) HS15) investigated in vitro in cell cultures","volume":"32","author":"Shubber","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2017.03.007_bb0200","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jconrel.2014.04.021","article-title":"Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases","volume":"190C","author":"Singh","year":"2014","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.tiv.2017.03.007_bb0205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/mutage\/gel019","article-title":"hOGG1 recognizes oxidative damage using the comet assay with greater specificity than FPG or ENDOIII","volume":"21","author":"Smith","year":"2006","journal-title":"Mutagenesis"},{"issue":"11","key":"10.1016\/j.tiv.2017.03.007_bb0210","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.2337\/db06-0188","article-title":"Saturated, but not unsaturated, fatty acids induce apoptosis of human coronary artery endothelial cells via nuclear factor-kappaB activation","volume":"55","author":"Staiger","year":"2006","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.tiv.2017.03.007_bb0215","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/10408440903120975","article-title":"Development of in vitro systems for nanotoxicology: methodological considerations","volume":"39","author":"Stone","year":"2009","journal-title":"Crit. Rev. Toxicol."},{"issue":"2","key":"10.1016\/j.tiv.2017.03.007_bb0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2004.07.006","article-title":"Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity","volume":"23","author":"Vellonen","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.tiv.2017.03.007_bb0225","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jbm.a.30711","article-title":"Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake","volume":"78","author":"Vonarbourg","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.tiv.2017.03.007_bb0230","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2147\/IJN.S28531","article-title":"Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages","volume":"7","author":"Yu","year":"2012","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.tiv.2017.03.007_bb0235","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/en.2009-1082","article-title":"Nanoparticles and the immune system","volume":"151","author":"Zolnik","year":"2010","journal-title":"Endocrinology"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233317300711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233317300711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T11:51:31Z","timestamp":1535975491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233317300711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":49,"alternative-id":["S0887233317300711"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2017.03.007","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxicity and genotoxicity of lipid nanocapsules","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2017.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}